Quantum Biopharma Ltd. filed its report with the SEC on April 14, 2025, in compliance with the Securities Exchange Act of 1934. The filing indicates that the company continues its registration process and will file annual reports under Form 20-F, signifying ongoing compliance with regulatory requirements.